Contact
Please use this form to send email to PR contact of this press release:
Akari Therapeutics Announces Phase II COBALT trial of Coversin™ in Patients with PNH Met the Primary Endpoint
TO:
Please use this form to send email to PR contact of this press release:
Akari Therapeutics Announces Phase II COBALT trial of Coversin™ in Patients with PNH Met the Primary Endpoint
TO: